Supranormal renal function in unilateral hydronephrotic kidney can be avoided

Clinical Nuclear Medicine

Volumn 29, Issue 7, 2004, Pages 410-414

  Khan, Jehanzeb ^a   Charron, Martin ^b   Hickeson, Marc P ^a   Accorsi, Roberto ^b   Qureshi, S ^c   Canning, Douglas ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

Artifact; Hydronephrosis; Supranormal function

Indexed keywords

MERTIATIDE TC 99M;

ALGORITHM; ARTIFACT; CHILD; COMPUTER PROGRAM; DIFFERENTIAL KIDNEY FUNCTION; FEMALE; HUMAN; HYDRONEPHROSIS; IMAGE RECONSTRUCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PHANTOM; REVIEW; SUPRANORMAL KIDNEY FUNCTION; UNILATERAL HYDRONEPHROSIS; URINARY TRACT OBSTRUCTION;

ARTIFACTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDRONEPHROSIS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; KIDNEY; KIDNEY CORTEX; MALE; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SOFTWARE; TECHNETIUM TC 99M MERTIATIDE; URETERAL OBSTRUCTION;

EID: 2942694374     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000129118.91958.16     Document Type: Review

References (22)

1. Gupta DK, Chandrasekharam VVSS, Srinivas M, et al. Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function. Urology. 2001;57:547-550.
2. Shokeir AA, Provoost AP, Nijman RJ. Recoverability of renal function after relief of chronic partial upper urinary tract obstruction. BJU Int. 1999;83:11-17.
3. Koff SA, Campbell KD. The nonoperative management of unilateral neonatal hydronephrosis: natural history of poorly functioning kidneys. J Urol. 1994;152:593-595.
4. Fung LC, McLorie GA, Khoury AE, et al. Contradictory supranormal nuclear renographic differential renal function: fact or artifact? J Urol. 1995;154:667-670.
5. Steiner D, Steiss JO, Klett R, et al. The value of renal scintigraphy during controlled diuresis in children with hydronephrosis. Eur J Nucl Med. 1999;26:938-939.
6. Saunders CA, Choong KK, Larcos G, et al. Assessment of pediatric hydronephrosis using output efficiency. J Nucl Med. 1997;38:1483-1486.
7. Steckler RE, McLorie GA, Jayanthi VR, et al. Contradictory supranormal differential renal function during nuclear renographic investigation of hydroureteronephrosis. J Urol. 1994;152:600-602; discussion 602-603.
8. Gluckman GR, Baskin LS, Bogaert GA, et al. Contradictory renal function measured with mercaptoacetyltriglycine diuretic renography in unilateral hydronephrosis. J Urol. 1995;154:1486-1489; discussion 1489-1490.
9. Oh SJ, Moon DH, Kang W, et al. Supranormal differential renal function is real but may be pathological: assessment by 99m technetium mercaptoacetyltriglycine renal scan of congenital unilateral hydronephrosis. J Urol. 2001;165:2300-2304.
10. O'Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrology Group. Consensus Committee on Diuresis Renography. J Nucl Med. 1996;37:1872-1876.
11. Nguyen HT, Gluckman GR, Kogan BA. Changing the technique of background subtraction alters calculated renal function on pediatric mercaptoacetyltriglycine renography. J Urol. 1997;158:1252-1256.
12. Piepsz A, Tondeur M, Ham H. Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy. J Nucl Med. 1999;40:972-976.
13. Taylor A Jr, Clark S, Ball T. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates. Clin Nucl Med. 1994; 19:575-580.
14. Fritzberg AR, Kasina S, Eshima D, et al. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111-116.
15. Bair HJ, Becker W, Schott G, et al. Is there still a need for Tc-99m DMSA renal imaging? Clin Nucl Med. 1995;20:18-21.
16. Eshima D, Taylor A Jr. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent. Semin Nucl Med. 1992;22:61-73.
17. Meyer G, Piepsz A, Kolinska J, et al. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined? Eur J Nucl Med. 1998;25:760-765.
18. Bubeck B, Brandau W, Weber E, et al. Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med. 1990;31:1285-1293.
19. Saunders CA, Choong KK, Larcos G, et al. Assessment of pediatric hydronephrosis using output efficiency. J Nucl Med. 1997;38:1483-1486.
20. Taylor A Jr, Thakore K, Folks R, et al. Background subtraction in technetium-99m-MAG3 renography. J Nucl Med. 1997;38:74-79.
21. Inoue Y, Yoshikawa K, Yoshioka N, et al. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest. J Nucl Med. 2000;41:1947-1954.
22. 99mTc-mercaptoacetyltriglycine scintigraphy in relation to the extent of hydronephrosis for predicting ureteropelvic junction obstruction in the newborn. J Nucl Med. 2003;44:725-731.